And the serum trait, i.e., fasting glucose, TC, LDL, TG, and ALT, were statistically greater in lean NAFLD compared with lean non-NAFLD individuals (p < .05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.